1. Home
  2. XYLO vs PRFX Comparison

XYLO vs PRFX Comparison

Compare XYLO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • PRFX
  • Stock Information
  • Founded
  • XYLO 1999
  • PRFX 2007
  • Country
  • XYLO Israel
  • PRFX Israel
  • Employees
  • XYLO N/A
  • PRFX N/A
  • Industry
  • XYLO
  • PRFX Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • PRFX Health Care
  • Exchange
  • XYLO NYSE
  • PRFX Nasdaq
  • Market Cap
  • XYLO 3.1M
  • PRFX 3.0M
  • IPO Year
  • XYLO N/A
  • PRFX 2020
  • Fundamental
  • Price
  • XYLO $3.81
  • PRFX $3.16
  • Analyst Decision
  • XYLO
  • PRFX Hold
  • Analyst Count
  • XYLO 0
  • PRFX 1
  • Target Price
  • XYLO N/A
  • PRFX N/A
  • AVG Volume (30 Days)
  • XYLO 9.8K
  • PRFX 3.2M
  • Earning Date
  • XYLO 09-20-2024
  • PRFX 01-01-0001
  • Dividend Yield
  • XYLO N/A
  • PRFX N/A
  • EPS Growth
  • XYLO N/A
  • PRFX N/A
  • EPS
  • XYLO N/A
  • PRFX N/A
  • Revenue
  • XYLO $57,642,000.00
  • PRFX N/A
  • Revenue This Year
  • XYLO $16.76
  • PRFX N/A
  • Revenue Next Year
  • XYLO $5.71
  • PRFX N/A
  • P/E Ratio
  • XYLO N/A
  • PRFX N/A
  • Revenue Growth
  • XYLO N/A
  • PRFX N/A
  • 52 Week Low
  • XYLO $2.70
  • PRFX $0.43
  • 52 Week High
  • XYLO $8.83
  • PRFX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 39.04
  • PRFX 49.34
  • Support Level
  • XYLO $4.08
  • PRFX $3.22
  • Resistance Level
  • XYLO $5.33
  • PRFX $5.47
  • Average True Range (ATR)
  • XYLO 0.49
  • PRFX 0.34
  • MACD
  • XYLO -0.09
  • PRFX 0.04
  • Stochastic Oscillator
  • XYLO 0.00
  • PRFX 15.97

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: